7 Hills Pharma appoints Michael S. Perry, CEO of AVITA Medical, as its first Chairman of the Board of Managers. The company is advancing small molecule integrin activators, including 7HP349, to enhance immuno-oncology drugs and vaccines for COVID-19, influenza, and cancer treatments.

7 Hills Pharma appoints Dr. Lionel D. Lewis as Chief Medical Officer, bringing extensive immuno-oncology expertise to advance 7HP349 integrin activator for solid tumor treatment. Learn more about this leadership addition.